A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT04184882 · TERMINATED
Trial details
- NCT number
- NCT04184882
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2022-09-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.